Breaking News
Investing Pro 0
New Year’s SALE: Up to 40% OFF InvestingPro+ CLAIM OFFER
Close

Sanofi ADR (SNY)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Sanofi ADR's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
48.81 -0.08    -0.16%
20:59:59 - Closed. Currency in USD ( Disclaimer )
After Hours
48.78
-0.03
-0.06%
21:08:44 - Real-time Data
  • Volume: 2,238,703
  • Bid/Ask: 48.82 / 50.00
  • Day's Range: 48.66 - 49.17
Type:  Equity
Market:  United States
Sanofi ADR 48.81 -0.08 -0.16%

SNY Income Statement

 
Assess the Sanofi ADR income statement, view the company's financial performance across their assets and liabilities. Select to view either quarterly or annual data.
AnnualQuarterly
InvestingPro Advanced Income Statement
Period Ending: 2022
30/09
2022
30/06
2022
31/03
2021
31/12
Total Revenue 13138 10742 10053 10415
Revenue 12482 10116 9674 9994
Other Revenue, Total 656 626 379 421
Cost of Revenue, Total 3831 3250 2880 3472
Gross Profit 9307 7492 7173 6943
Total Operating Expenses 8486 8762 7480 9162
Selling/General/Admin. Expenses, Total 2644 2600 2379 2802
Research & Development 1736 1658 1489 1586
Depreciation / Amortization - - 449 805
Interest Expense (Income) - Net Operating -103 -88 -88 -113
Unusual Expense (Income) - - 198 512
Other Operating Expenses, Total 378 1342 820 1415
Operating Income 4652 1980 2573 1253
Interest Income (Expense), Net Non-Operating - - -78 -153
Gain (Loss) on Sale of Assets - 298 - 421
Other, Net 1972 299 224 -575
Net Income Before Taxes 2680 1383 2349 1407
Provision for Income Taxes 601 163 332 267
Net Income After Taxes 2079 1220 2017 1140
Minority Interest - 353 -8 350
Equity In Affiliates - - 30 13
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 2076 1175 2009 1130
Total Extraordinary Items - - - -
Net Income 2076 1175 2009 1130
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items 2076 1175 2009 1130
Dilution Adjustment - -4.46 - -3.6
Diluted Net Income 2076 1179.46 2009 1133.6
Diluted Weighted Average Shares 1253.5 1250.8 1249.2 1254.9
Diluted EPS Excluding Extraordinary Items 1.66 0.939 1.61 0.9
DPS - Common Stock Primary Issue - - - 3.33
Diluted Normalized EPS 2.3 0.942 1.26 0.605
* In Millions of EUR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SNY Comments

Write your thoughts about Sanofi ADR
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email